Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine adjunct therapy versus placebo in chronic non-bacterial prostatitis
IRCT20120215009014N318Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Prostatodynia (CP/CPPS) comparing Tamsulosin + n-acetylcysteine with Tamsulosin + placebo (2 arms). Primary endpoints: Clinical outcome, Pain severity and 1 more. Started Dec 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on IRCT20120215009014N318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N318.